This invention relates to a woven fabric suitable for use in implantable medical devices and, more particularly, to a textured woven fabric suitable for use for in implantable bioprosthetic heart valves.
Implantable medical devices often incorporate textiles and fabrics that can fulfill a variety of different functions, depending on the nature and type of the medical device and the site of implantation in a patient.
Implantable bioprosthetic heart valves and stent grafts, for example, often include a layer of fabric, such as an outer covering or inner or outer fabric skirt, which is attached to a metal frame or stent. In the case of bioprosthetic heart valves, the fabric skirt can be used to anchor the valve leaflets to the stent. The fabric skirt can also function to protect the delicate valve leaflets from damage that may otherwise occur from direct contact between the valve leaflets and the stent when the heart valve is radially compressed for delivery through a patient's vasculature.
Cellular and tissue in-growth may be desired for certain implantable medical devices. One reason for this is that it may prevent the implantable medical device from becoming dislodged from the site of implantation. Another reason, particularly with respect to bioprosthetic heart valves, is that it may help prevent the occurrence of paravalvular leakage (PVL), which occurs when blood flows through a space between the implanted bioprosthetic heart valve and the adjacent tissue.
The textured fabrics described herein provide a three-dimensional cloth that can be used in connection with implantable medical devices. The textured fabric can be used as, for example, a skirt that surrounds at least a periphery of an implantable bioprosthetic heart valve.
The textured fabrics can comprise two discrete layers: a base layer and a loop layer. The base layer can be woven and can provide permeability and suture retention strength, as desired. The loop layer can comprise a composite core-sheath yarn, with a core that can be resistant to bending such that it can fill gaps that may exist between, for example, an implanted bioprosthetic heart valve and surrounding tissue. The core yarn can therefore provide improved sealing to mitigate the occurrence of PVL. At the same time, the sheath yarn can be made from a material that is softer than the core yarn to protect the tissue from damage that may otherwise result. The sheath yarn can also be a textured or multifilament yarn that permits cellular and tissue in-growth with the surrounding tissue.
In one embodiment in which the textured fabric is provided to cover a portion of an implantable bioprosthetic heart valve, the composite core-sheath yarns that are used to make up the plurality of loops can provide improved sealing with the surrounding tissue and improved suture retention. These improvements are due to combination of the core yarn's relative strength and resistance to bending, which permits plurality of loops to fill a volume of space or gaps that may exist between the implanted bioprosthetic heart valve and the surrounding tissue. At the same time, the sheath yarns can provide a soft, textured surface that, in combination with the core yarns, not only assists in filling the volume of space or gaps, but also prevents damage to the surrounding tissue.
In one embodiment, a textured fabric for a bioprosthesis is provided. The textured fabric comprises a base layer and a plurality of loops projecting from the base layer. The plurality of loops can be formed from a composite core-sheath yarn. The composite core-sheath yarn can comprise a core and a sheath, wherein the sheath is made from a material different from the core.
In a separate optional aspect, the base layer can be a woven base layer comprising warp and weft yarns.
In another separate optional aspect, the warp and weft yarns can be made from a material each independently selected from the group consisting of: polyester, polyethylene, ultra-high molecular-weight polyethylene (“UHMWPE”), polypropylene, polytetrafluoroethylene (“PTFE”), expanded PTFE (“ePTFE”), and nylon.
In another separate optional aspect, the warp and weft yarns can be made of the same material.
In another separate optional aspect, the warp and weft yarns can be made of different materials.
In another separate optional aspect, the warp and weft yarns of the base layer can have a diameter of about 20 microns to about 70 microns.
In another separate optional aspect, the base layer can have an ends per inch or EPI of about 150 to about 300.
In another separate optional aspect, the base layer can have a picks per inch or PPI of about 100 to about 250.
In another separate optional aspect, the composite core-sheath yarn can comprise a core that is made from a monofilament yarn or a shape memory material.
In another separate optional aspect, the core can be made from a shape memory material and the shape memory material can be an alloy of nickel and titanium.
In another separate optional aspect, the core can be a monofilament yarn selected from the group consisting of: polyester, polyethylene, UHMWPE, polypropylene, PTFE, ePTFE, and nylon.
In another separate optional aspect, the sheath can be made of a textured multifilament yarn.
In another separate optional aspect, the sheath can have a denier of from about 15 to about 40.
In another separate optional aspect, the sheath can have a filament count of from about 5 to about 20.
In another separate optional aspect, the sheath can have a diameter of about 25 microns to about 250 microns.
In another separate optional aspect, the textured fabric can have a loop density of about 400 loops/in2 to about 1,000 loops/in2.
In another separate optional aspect, the loop height can be about 0.0250 inches to about 0.1000 inches.
In another separate optional aspect, the core-sheath yarn can have a twists per inch or TPI of about 20 to about 40.
In another separate optional aspect, the sheath can be wrapped around a core with the sheath being provided externally of the core.
In another separate optional aspect, the core is not wrapped around the sheath.
In another separate optional aspect, a bioprosthetic heart valve is provided that comprises the textured fabric in accordance with any one or a combination of the separate optional aspects described above.
Other objects, features and advantages of the described preferred embodiments will become apparent to those skilled in the art from the following detailed description. It is to be understood, however, that the detailed description and specific examples, while indicating preferred embodiments of the present invention, are given by way of illustration and not limitation. Many changes and modifications within the scope of the present invention may be made without departing from the spirit thereof, and the invention includes all such modifications.
Preferred and non-limiting embodiments of the inventions may be more readily understood by referring to the accompanying drawings in which:
Like numerals refer to like parts throughout the several views of the drawings.
Specific, non-limiting embodiments of the present invention will now be described with reference to the drawings. It should be understood that such embodiments are by way of example only and merely illustrative of but a small number of embodiments within the scope of the present invention. Various changes and modifications obvious to one skilled in the art to which the present invention pertains are deemed to be within the spirit, scope and contemplation of the present invention as further defined in the appended claims.
Described herein are textured fabrics comprising a woven base layer made from one or a combination of different yarns for the warp and weft yarns and a plurality of loops interlaced with the weft yarn. The warp and weft yarns can be made from the same or from different materials and the loops can be made of a composite yarn that is formed by spiral wrapping a core yarn with a sheath yarn. In one embodiment, only the sheath yarn comprises spiral turns around a core yarn, as depicted in
As used herein, “yarns” are understood to comprise one or more filaments and thus include monofilament yarns, multifilament yarns and composite yarns comprising any combination of monofilament and/or multifilament yarns, such as composite core-sheath yarns.
The woven base layer can be configured to have any one or more of the following characteristics, depending on the application of the textured fabric: (1) a relatively low thickness or profile; (2) resistance to stretching or shrinking; and (3) permeability to fluids and, more particularly, to bodily fluids such as blood.
The woven base layer is understood to be distinguishable from knitted fabrics in that the woven base layer is constructed by interlacing or weaving lengthwise and crosswise at least two yarns, called warp and weft yarns, to create the woven base layer. In certain embodiments, the woven base layer does not have a great degree of stretchability due to the nature of its construction of interlaced warp and weft yarn. Of course, selection of stretchable yarns in the construction of the woven base layer can impart stretchability of the resulting woven base layer. This is in contrast to a knitted fabric, which is made from interlocking loops that impart a greater degree of stretchability to the resulting knitted fabric, regardless of whether or not the yarns themselves are stretchable.
Thus, in one embodiment, the warp and weft yarns of the woven base layer can be made from yarns that do not stretch to a significant degree, for example, less than about 25%, less than about 20%, less than about 15%, less than about 10%, less than about 5%, or less than about 1%.
In one aspect, the warp and weft yarns of the woven base layer can be made of the same yarn. In another aspect, the warp and weft yarns can each be made of a plurality of different yarns. In a further aspect, the warp and weft can be made from different yarns.
The thickness or profile of the woven base layer can be selected by using warp and weft yarns of a pre-selected diameter, a pre-selected denier, a pre-selected filament count, or any combination of the foregoing depending on the type of yarns used.
In one embodiment, the warp and weft yarns of the woven base layer can each independently have a diameter of about 10 microns, about 15 microns, about 20 microns, about 25 microns, about 30 microns, about 35 microns, about 40 microns, about 45 microns, about 50 microns, about 55 microns, about 60 microns, about 65 microns, about 70 microns, about 75 microns, or about 80 microns. In a preferred embodiment, the diameters of the warp and weft yarns of woven base layer can separately be provided within a range between and including any two of the foregoing values. For example, the diameters of the warp and weft yarns of the woven base layer can be provided in the range of about 20 microns to about 70 microns.
In another embodiment, the warp or weft yarns of the woven base layer can each independently have a denier of about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 71, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 86, 87, 88, 89, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, or 100. In a preferred embodiment, the denier for warp or weft yarns of the woven base layer can separately be provided within a range between and including any two of the foregoing values. For example, the denier for the warp or weft yarns of the woven base layer yarn can be provided in the range of about 7 denier to about 70 denier.
In a further embodiment, the warp and weft yarns of the woven base layer can each independently have a filament count of about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, or 60. In a preferred embodiment, the filament count for each of the warp and weft yarns can independently be provided within a range between and including any two of the foregoing values. For example, the filament count can be provided in a range of about 5 to about 40 filaments.
The permeability of the woven base layer can be adjusted by varying the pore sizes of the woven base layer as defined by adjacent warp and weft yarns. This can be accomplished by the selection of the yarns and/or by varying the ends per inch and the picks per inch of the woven base layer.
In one embodiment, the ends per inch (EPI) for the woven base layer can be about 100 EPI, 105 EPI, 110 EPI, 115 EPI, 120 EPI, 125 EPI, 130 EPI, 135 EPI, 140 EPI, 145 EPI, 150 EPI, 155 EPI, 160 EPI, 165 EPI, 170 EPI, 175 EPI, 180 EPI, 185 EPI, 190 EPI, 195 EPI, 200 EPI, 205 EPI, 210 EPI, 215 EPI, 220 EPI, 225 EPI, 230 EPI, 235 EPI, 240 EPI, 245 EPI, 250 EPI, 255 EPI, 260 EPI, 265 EPI, 270 EPI, 275 EPI, 280 EPI, 285 EPI, 290 EPI, 295 EPI, 300 EPI, 305 EPI, 310 EPI, 315 EPI, 320 EPI, 325 EPI, 330 EPI, 335 EPI, 340 EPI, 345 EPI, or 350 EPI. In a preferred embodiment, the EPI can be provided within a range between and including any two of the foregoing values. For example, the EPI can be provided in the range of about 150 to about 300 EPI.
In another embodiment, the picks per inch (PPI) for the woven base layer can be about 50 PPI, 55 PPI, 60 PPI, 65 PPI, 70 PPI, 75 PPI, 80 PPI, 85 PPI, 90 PPI, 95 PPI, 100 PPI, 105 PPI, 110 PPI, 115 PPI, 120 PPI, 125 PPI, 130 PPI, 135 PPI, 140 PPI, 145 PPI, 150 PPI, 155 PPI, 160 PPI, 165 PPI, 170 PPI, 175 PPI, 180 PPI, 185 PPI, 190 PPI, 195 PPI, 200 PPI, 205 PPI, 210 PPI, 215 PPI, 220 PPI, 225 PPI, 230 PPI, 235 PPI, 240 PPI, 245 PPI, 250 PPI, 255 PPI, 260 PPI, 265 PPI, 270 PPI, 275 PPI, 280 PPI, 285 PPI, 290 PPI, 295 PPI, or 300 PPI. In a preferred embodiment, the PPI can be provided within a range between and including any two of the foregoing values. For example, the PPI can be provided in the range of about 100 to about 250 PPI.
The permeability of the woven base layer can also be adjusted by selecting a specific weave pattern. The weave pattern for the woven base layer can be plain, twill or satin.
A plurality of loops can be provided in conjunction with the woven base layer to provide a textured surface that facilitates cellular and tissue in-growth. The plurality of loops can also fill a volume of space between a bioprosthesis and an adjacent tissue at the site of implantation. This may be particularly desirable for bioprosthetic heart valves and, in particular, for the prevention of PVL that can result from inadequate sealing between the implant and the surrounding tissue. The plurality of loops can be provided to fill an open volume or space between the bioprosthetic heart valve and the tissue at the site of implantation to facilitate cellular and tissue in-growth and also to prevent or block the occurrence of PVLs.
The height of the individual loops and the loop density provided on the woven base layer can be adjusted based on the desired volume that is sought to be filled at the implantation site.
The plurality of loops can each have a loop height of about 0.0200 inches, 0.0250 inches, 0.0300 inches, 0.0350 inches, 0.0400 inches, 0.0450 inches, 0.0500 inches, 0.0550 inches, 0.0600 inches, 0.0650 inches, 0.0700 inches, 0.0750 inches, 0.0800 inches, 0.0850 inches, 0.0900 inches, 0.0950 inches, 0.1000 inches, 0.1050 inches, or 0.1100 inches. In a preferred embodiment, the loop height can be provided within a range between and including any two of the foregoing values. For example, the loop height can be provided in the range of from about 0.0250 inches to about 0.1000 inches.
The plurality of loops can have a loop density of about 300 loops/in2, 350 loops/in2, 400 loops/in2, 450 loops/in2, 500 loops/in2, 550 loops/in2, 600 loops/in2, 650 loops/in2, 700 loops/in2, 750 loops/in2, 800 loops/in2, 850 loops/in2, 900 loops/in2, 950 loops/in2, 1,000 loops/in2, 1,050 loops/in2, 1,100 loops/in2, 1,150 loops/in2, or 1,200 loops/in2. In a preferred embodiment, the loop density can be provided within a range between and including any two of the foregoing values. For example, the loop density can be provided in the range from about 400 loops/in2 to about 1,000 loops/in2.
Each of the plurality of loops can be formed from composite core-sheath yarns. The composite core-sheath yarns can be comprised of at least two different types of materials. The core can be made of a material such that the formed loop is compressible and returns to its loop shape when compression is released. The core can be made of a resilient material that is more resistant to bending than the sheath material. The sheath material can be made of a textured material with a relatively softer and larger surface area than the core. The softer material of the sheath can help protect the tissue from damage that may otherwise result. The textured surface of the sheath can facilitate cellular infiltration and in-growth.
In one embodiment in which the textured fabric is provided to cover a portion of an implantable bioprosthetic heart valve, the composite core-sheath yarns that are used to make up the plurality of loops can provide improved sealing with the surrounding tissue and improved suture retention. These improvements are due to combination of the core yarn's relative strength and resistance to bending, which permits plurality of loops to fill a volume of space or gaps that may exist between the implanted bioprosthetic heart valve and the surrounding tissue. At the same time, the sheath yarns can provide a soft, textured surface that, in combination with the core yarns, not only assists in filling the volume of space or gaps, but also prevents damage to the surrounding tissue.
In one embodiment, the resiliency and the resistance to bending of the core yarn of the core-sheath yarn can result from selecting a material for the core yarn that is more resistant to bending or is stiffer than the sheath yarn. The core yarn can be made of, for example, a monofilament yarn or a shape memory material or alloy, such as a super elastic nitinol. The resiliency and resistance to bending of the core yarn can also be increased by increasing the diameter of the core yarn.
On the other hand, sheath yarn can be selected to provide an outer surface that is soft, textured, has a high surface area, or any combination of the foregoing, so as to promote cellular or tissue in-growth and also to prevent damage to the surrounding tissue. These properties can be enhanced by selecting the appropriate diameter, denier, filament count or any of the foregoing for the sheath yarn. Additionally, the sheath yarn can be provided to have a greater surface area per unit length than the core yarn.
In one embodiment, the diameter of the core material of the core-sheath yarn can depend upon the inherent stiffness of the material selected. The greater the inherent stiffness, the smaller the diameter. The diameter of the core yarn can be about 0.0005 inches, 0.0010 inches, 0.0015 inches, 0.0020 inches, 0.0025 inches, 0.0030 inches, 0.0035 inches, 0.0040 inches, 0.0045 inches, 0.0050 inches, 0.0055 inches, 0.0060 inches, 0.0065 inches, or 0.0070 inches. In one embodiment, the diameter of the core yarn can be less than 0.0005 inches or greater than 0.0070 inches. In another embodiment, the diameter of the core yarn can be provided within a range between and including any two of the foregoing values. For example, the range can be from about 0.0005 inches to about 0.0020 inches. In one embodiment, the diameter of the core yarn can be less than the diameter of the sheath yarn. In another embodiment, the diameter of the core yarn can be greater than the diameter of the sheath yarn.
The sheath material of the core-sheath yarn can be made from a textured yarn, preferably a multifilament yarn. In one embodiment, the textured yarn can have a denier of about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment the denier can be greater than 50. In another embodiment, the denier can be provided within a range between and including any two of the foregoing values. For example, the denier can be provided in the range of from about 15 to about 40.
The sheath material of the core-sheath yarn can also be made from a textured yarn having a filament count that facilitates cellular or tissue in-growth. In one embodiment, the filament count can be about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, or 50. In one embodiment, the filament count can be greater than 50. In another embodiment, the filament count can be provided within a range between and including any two of the foregoing values. For example, the filament count can be provided in the range of about 5 to about 20. The higher the filament count, the greater the surface area to facilitate cellular and tissue in-growth.
The diameter of the sheath material can also be selected. In one embodiment, the diameter of the material, in microns, can be about 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 80, 90, 100, 110, 120, 130, 140, 150, 160, 170, 180, 190, 200, 210, 220, 230, 240, 250, 260, or 270. Ina further embodiment, the diameter can be greater than 270 microns. In yet a further embodiment, the diameter can be provided within a range between and including any two of the foregoing values. For example, the diameter can be provided within a range of about 25 microns to about 250 microns.
The parameters of coil length and coil pitch of the sheath material influences the extent to which the sheath material covers the core material. These parameters can be controlled by the rotational speed of two hollow spindles that are normally used for making the composite core-sheath yarn, the delivery speed of the sheath material and the core stretch ratio during wrapping.
In one embodiment, the sheath material of the core-sheath yarn is characterized as having a twist per inch (TPI) of about 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, or 60. As used herein, the TPI refers to the number of twists of only the sheath material around the core in a single linear inch along the core length. In one embodiment, the TPI count can be less than 5 or greater than 60. In another embodiment, the TPI can be provided within a range between and including any two of the foregoing values. For example, the TPI can be provided in the range of about 10 to about 25 or about 20 to about 40.
It is understood that the processing parameters for creating a core-sheath yarn having a TPI of a specific value or within a range of values depends on a number of parameters. As previously described, the composite core-sheath yarn is a two-component structure that is produced by, for example, a ring spinning system. Among the parameters that affect the resulting TPI of the composite core-sheath yarn is the core stretch ratio, which is governed by the relative speed of the pre-draft roller and the delivery roller of the ring spinning system. The sheath yarn is spiral wrapped between the portion of the core yarn that extends between, or in some instances, is stretched between the pre-draft and delivery rollers.
In one embodiment, the core stretch ratio is about 1 in which the speed of the pre-draft roller and the delivery roller are the same. In another embodiment, the core stretch ratio is greater than 1, in which the speed of the delivery roller is greater than the speed of the pre-draft roller. In accordance with this embodiment, the core stretch ratio can be about 1.1, 1.2, 1.3, 1.4, 1.5, 1.6, 1.7, 1.8, 1.9, 2.0, 2.1, 2.2, 2.3, 2.4, 2.5, 2.6, 2.7, 2.8, 2.9, 3.0, 3.1, 3.2, 3.3, 3.4, 3.5, 3.6, 3.7, 3.8, 3.9, or 4.0. In one embodiment, the core stretch ratio can be greater than 4.0. In another embodiment, the core stretch ratio can be provided within a range between and including any two of the foregoing values. For example, the core stretch ratio can be provided in the range of about 1.5 to about 3.5. In a further embodiment, the core stretch ratio can be provided in the range of about 2.4 to about 2.8.
In one embodiment, the desired loop height and width can be controlled by the diameter of the metal rods or wires 10 that is placed directly adjacent the woven base layer. As depicted in
The textured woven fabrics described herein can be incorporated in any suitable medical device that is introduced temporarily or permanently into the body for the treatment of a medical condition. Such medical devices can include, but are not limited to, prosthetic heart valves, annuloplasty rings, docking devices such as pre-stents or coils that retain other implanted devices, endovascular grafts, stent grafts, meshes, vascular grafts, tissue scaffolds, myocardial plugs, venous valves, and other known biocompatible devices.
The textured fabrics described herein are particularly suitable for implantable medical devices for which attachment to a biological tissue and cellular and tissue in-growth is desired. For example, the textured fabrics are particularly suitable for bioprosthetic heart valves and various types of vascular stents. In the case of bioprosthetic heart valves, the textured fabrics can be particularly suitable for use as an inner or outer skirt that can cover a frame or a stent. Exemplary heart valves for which the textured woven fabrics can be used are described in U.S. Pub. No. 2012/0123529, published on May 17, 2012, the entire contents of which are incorporated herein by reference in their entirety.
It is to be understood that the detailed description and specific examples, while indicating preferred embodiments of the present disclosure, are given by way of illustration and not limitation. Many changes and modifications within the scope of the present disclosure may be made without departing from the spirit thereof, and the disclosure includes all such modifications.
This application claims the benefit of priority under 35 U.S.C. § 119(e) to U.S. Provisional Patent Application Ser. No. 62/268,363, filed on Dec. 16, 2015, the entire contents of which are incorporated by reference as if fully set forth herein.
Number | Name | Date | Kind |
---|---|---|---|
3058290 | Leslie | Oct 1962 | A |
3763858 | Buese | Oct 1973 | A |
3983761 | Stewart | Oct 1976 | A |
3988490 | Holroyd | Oct 1976 | A |
4035849 | Angell et al. | Jul 1977 | A |
4078110 | Fletcher | Mar 1978 | A |
4084622 | Nakagawa | Apr 1978 | A |
4191221 | Boyer | Mar 1980 | A |
4324824 | Narens | Apr 1982 | A |
4340091 | Skelton | Jul 1982 | A |
4404703 | Woodall, Jr. | Sep 1983 | A |
4404999 | Woodall, Jr. | Sep 1983 | A |
4420529 | Westhead | Dec 1983 | A |
4467839 | Westhead | Aug 1984 | A |
4662886 | Moorse | May 1987 | A |
4739635 | Conley | Apr 1988 | A |
4892539 | Koch | Jan 1990 | A |
5024851 | Goad | Jun 1991 | A |
5047285 | Ward | Sep 1991 | A |
5114788 | Nakagawa | May 1992 | A |
5119643 | Conley | Jun 1992 | A |
5178630 | Schmitt | Jan 1993 | A |
5215816 | Shibata | Jun 1993 | A |
5232759 | Golze | Aug 1993 | A |
5236447 | Kubo | Aug 1993 | A |
5244718 | Taylor | Sep 1993 | A |
5282846 | Schmitt | Feb 1994 | A |
5282848 | Schmitt | Feb 1994 | A |
5411552 | Andersen et al. | May 1995 | A |
5424117 | Heiman | Jun 1995 | A |
5554185 | Block et al. | Sep 1996 | A |
5806155 | Malaney | Sep 1998 | A |
5840081 | Andersen et al. | Nov 1998 | A |
6168614 | Andersen et al. | Jan 2001 | B1 |
6202264 | Ishihara | Mar 2001 | B1 |
6346492 | Koyfman | Feb 2002 | B1 |
6458153 | Bailey et al. | Oct 2002 | B1 |
6582462 | Andersen et al. | Jun 2003 | B1 |
6652578 | Bailey et al. | Nov 2003 | B2 |
6689162 | Thompson | Feb 2004 | B1 |
7018408 | Bailey et al. | Mar 2006 | B2 |
7083644 | Moroni | Aug 2006 | B1 |
7618446 | Andersen et al. | Nov 2009 | B2 |
7785366 | Maurer et al. | Aug 2010 | B2 |
7820565 | van Heerden | Oct 2010 | B2 |
7964206 | Suokas | Jun 2011 | B2 |
8449606 | Eliasen et al. | May 2013 | B2 |
8726479 | Kufferath-Kassner | May 2014 | B2 |
8940041 | Carlson et al. | Jan 2015 | B2 |
9216100 | Seibold | Dec 2015 | B2 |
10221506 | Yenici | Mar 2019 | B2 |
10472744 | Agarwal | Nov 2019 | B2 |
10562484 | Helvoort | Feb 2020 | B2 |
10683593 | Gupta | Jun 2020 | B2 |
10724165 | Tsiarkezos | Jul 2020 | B2 |
20030190853 | Lovingood | Oct 2003 | A1 |
20040097148 | Tucker, Jr. | May 2004 | A1 |
20040186589 | Bentele et al. | Sep 2004 | A1 |
20040215320 | Machek | Oct 2004 | A1 |
20050031828 | Yoshida | Feb 2005 | A1 |
20050081341 | McDougall | Apr 2005 | A1 |
20050096736 | Osse et al. | May 2005 | A1 |
20050124245 | Liao | Jun 2005 | A1 |
20050203614 | Forster et al. | Sep 2005 | A1 |
20050203617 | Forster et al. | Sep 2005 | A1 |
20050288775 | Dong | Dec 2005 | A1 |
20060009835 | Osborne | Jan 2006 | A1 |
20060025857 | Bergheim et al. | Feb 2006 | A1 |
20060089672 | Martinek | Apr 2006 | A1 |
20060128243 | Kong | Jun 2006 | A1 |
20070071941 | Eleazer | Mar 2007 | A1 |
20070203575 | Forster et al. | Aug 2007 | A1 |
20070265700 | Eliasen et al. | Nov 2007 | A1 |
20080125853 | Bailey et al. | May 2008 | A1 |
20080230140 | Santens | Sep 2008 | A1 |
20080300602 | Schmitt | Dec 2008 | A1 |
20090171440 | Carlson | Jul 2009 | A1 |
20090191777 | Liao | Jul 2009 | A1 |
20090218002 | Kashihara | Sep 2009 | A1 |
20120096690 | Chou | Apr 2012 | A1 |
20120116492 | Seibold | May 2012 | A1 |
20120165918 | Du | Jun 2012 | A1 |
20120171917 | Rasmussen | Jul 2012 | A1 |
20120290082 | Quint | Nov 2012 | A1 |
20130273795 | Richter | Oct 2013 | A1 |
20150127088 | Carlson et al. | May 2015 | A1 |
20150190552 | Richter | Jul 2015 | A1 |
20150203995 | Adams | Jul 2015 | A1 |
20150230953 | Bar et al. | Aug 2015 | A1 |
20150320556 | Levi | Nov 2015 | A1 |
20150354101 | Liao | Dec 2015 | A1 |
20160058524 | Tehrani | Mar 2016 | A1 |
20170088979 | Goenka | Mar 2017 | A1 |
20170088985 | Goenka | Mar 2017 | A1 |
20180103783 | Danaher | Apr 2018 | A1 |
20180168804 | Nguyen | Jun 2018 | A1 |
20180340273 | Goenka | Nov 2018 | A1 |
20180347078 | Goenka | Dec 2018 | A1 |
20190134271 | Seo | May 2019 | A1 |
20190159882 | Perkins | May 2019 | A1 |
20190223868 | Coffey | Jul 2019 | A1 |
Number | Date | Country |
---|---|---|
104786564 | Jul 2015 | CN |
19532846 | Mar 1997 | DE |
19907646 | Aug 2000 | DE |
0108171 | May 1984 | EP |
0592410 | Oct 1995 | EP |
1991017720 | Nov 1991 | WO |
0149213 | Jul 2001 | WO |
0247575 | Jun 2002 | WO |
2005084595 | Sep 2005 | WO |
2005102015 | Nov 2005 | WO |
2007067942 | Jun 2007 | WO |
2010121076 | Oct 2010 | WO |
2010139340 | Dec 2010 | WO |
Number | Date | Country | |
---|---|---|---|
20170172736 A1 | Jun 2017 | US |
Number | Date | Country | |
---|---|---|---|
62268363 | Dec 2015 | US |